# Abmart

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/abmart

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.ab-mart.com
- Total disclosed funding: $3.9M
- Latest round: Series B (Oct 14, 2016)
- Investors on record: 2

## About

Abmart is a China-based company that operates as a developer of monoclonal antibodies.

## Funding rounds

- Series B, Oct 14, 2016, $3M — Langsheng Investment
- Series B, Jul 25, 2011, $0.9M — NLVC

## Investors

- NLVC (https://capitalatlas.ai/funds/nlvc) — Series B
- Langsheng Investment (https://capitalatlas.ai/funds/langsheng-investment) — Series B